L Vellekoop
About
In The Last Decade
L Vellekoop
17 papers receiving 397 citations
Peers
Comparison fields: 5 of 45
- Hematology 307
- Oncology 141
- Genetics 112
- Public Health, Environmental and Occupational Health 80
- Molecular Biology 67
Countries citing papers authored by L Vellekoop
This map shows the geographic impact of L Vellekoop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Vellekoop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Vellekoop more than expected).
Fields of papers citing papers by L Vellekoop
This network shows the impact of papers produced by L Vellekoop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Vellekoop. The network helps show where L Vellekoop may publish in the future.
Co-authorship network of co-authors of L Vellekoop
This figure shows the co-authorship network connecting the top 25 collaborators of L Vellekoop. A scholar is included among the top collaborators of L Vellekoop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Vellekoop. L Vellekoop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia. | 4 |
| 2 | 16 | |
| 3 | Potential drugs for elimination of acute lymphatic leukemia cells from autologous bone marrow. | 9 |
| 4 | 8 | |
| 5 | 79 | |
| 6 | The role of autologous bone marrow transplantation in various malignancies. | 32 |
| 7 | 49 | |
| 8 | Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients. | 8 |
| 9 | Medulloblastoma and neuroblastoma in adults. | 5 |
| 10 | High-dose AMSA and bone marrow rescue in patients with solid tumors. | 9 |
| 11 | High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia. | 1 |
| 12 | Autologous bone marrow transplantation in neoplasia. | 11 |
| 13 | Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia. | 14 |
| 14 | 40 | |
| 15 | 51 | |
| 16 | 112 | |
| 17 | Myelopoietic enhancement by immunoadjuvants: in vitro studies for their rational use in neutropenic patients. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.